Difference between revisions of "Part:BBa K3717004"

Line 12: Line 12:
 
α-N-acetylgalactosaminidase is an enzyme that catalyzes the cleavage of the N-acetylgalactosamine off of A type blood antigens such that the remaining sugar can be classified as an H antigen, which the anti-A and anti-B antibodies are unable to recognize and thus does not elicit an immune response in the human body. Thus, the enzyme can convert A blood types to universal O type. While the enzyme has been previously shown to successfully convert A type erythrocytes to O type, it was inefficient in doing so, and lacked a cost-effective method of production.
 
α-N-acetylgalactosaminidase is an enzyme that catalyzes the cleavage of the N-acetylgalactosamine off of A type blood antigens such that the remaining sugar can be classified as an H antigen, which the anti-A and anti-B antibodies are unable to recognize and thus does not elicit an immune response in the human body. Thus, the enzyme can convert A blood types to universal O type. While the enzyme has been previously shown to successfully convert A type erythrocytes to O type, it was inefficient in doing so, and lacked a cost-effective method of production.
  
We obtained the amino acid sequence of the α-N-acetylgalactosaminidase protein, derived from  Elizabethkingia meningoseptica, from the iGEM DNA Repository Plate (BBa_K1483000), which served as our Open Reading Frame (ORF). We attached a strong promoter and strong ribosome binding site (RBS; BBa_K880005) upstream of the open reading frame (ORF). The composite gene was synthesized through DNA cloning.  
+
We obtained the amino acid sequence of the α-N-acetylgalactosaminidase protein, derived from  <i>Elizabethkingia meningoseptica</i>, from the iGEM DNA Repository Plate (BBa_K1483000), which served as our Open Reading Frame (ORF). We attached a strong promoter and strong ribosome binding site (RBS; BBa_K880005) upstream of the open reading frame (ORF). The composite gene was synthesized through DNA cloning.  
  
  
Line 43: Line 43:
  
 
α-N-Acetylgalactosaminidase part BBa_K1483000. Bottom sequence: First 38 amino acids of TAS_Taipei's α-N-Acetylgalactosaminidase part BBa_K3717016. Based on the alignment of the two sequences, Tuebingen's part is missing the first amino acid of the α-N-Acetylgalactosaminidase protein.
 
α-N-Acetylgalactosaminidase part BBa_K1483000. Bottom sequence: First 38 amino acids of TAS_Taipei's α-N-Acetylgalactosaminidase part BBa_K3717016. Based on the alignment of the two sequences, Tuebingen's part is missing the first amino acid of the α-N-Acetylgalactosaminidase protein.
 +
 +
 +
<b>References</b>
 +
 +
Rahfeld, Peter, and Stephen G. Withers. “Toward Universal Donor Blood: Enzymatic Conversion of A and B to O Type.” Journal of Biological Chemistry, vol. 295, no. 2, Jan. 2020, pp. 325–34. DOI.org (Crossref), https://doi.org/10.1074/jbc.REV119.008164.
 +
 +
XTractorTM Buffer & xTractor Buffer Kit User Manual. (n.d.). 10.
  
  

Revision as of 09:46, 19 October 2021


α-N-Acetylgalactosaminidase with strong promoter and RBS

T--TAS_Taipei--k88naga.jpg

Figure 1: α-N-Acetylgalactosaminidase with T7 promoter, RBS, and a terminator


Construct Design

α-N-acetylgalactosaminidase is an enzyme that catalyzes the cleavage of the N-acetylgalactosamine off of A type blood antigens such that the remaining sugar can be classified as an H antigen, which the anti-A and anti-B antibodies are unable to recognize and thus does not elicit an immune response in the human body. Thus, the enzyme can convert A blood types to universal O type. While the enzyme has been previously shown to successfully convert A type erythrocytes to O type, it was inefficient in doing so, and lacked a cost-effective method of production.

We obtained the amino acid sequence of the α-N-acetylgalactosaminidase protein, derived from Elizabethkingia meningoseptica, from the iGEM DNA Repository Plate (BBa_K1483000), which served as our Open Reading Frame (ORF). We attached a strong promoter and strong ribosome binding site (RBS; BBa_K880005) upstream of the open reading frame (ORF). The composite gene was synthesized through DNA cloning.


Results

We obtained the amino acid sequence of the α-N-Acetylgalactosaminidase protein from the iGEM DNA Repository Plate (BBa_K1483000), as entered into the iGEM parts collection database by the Tuebingen iGEM team in 2014.

In order to test protein expression of the enzyme, we added a strong promoter and strong ribosome binding site (RBS; BBa_K880005) upstream of the protein amino acid sequence to create a part BBa_K3717004.

T--TAS_Taipei--k88nagagelpic.jpg

Figure 2 - Colony PCR check for strong promoter (K88) α-N-Acetylgalactosaminidase (NAGA) (Part: BBa_K3717004) using VF2 and VR primers. Uncut plasmid (K88 only control) has a band at the expected part size of 355 bp, indicated by white triangle. Confirms successful ligation as a band is produced at the expected size of 1684 bp, as indicated by the red triangle.


We tested protein expression of these two composite parts by transforming our plasmids into BL21 E. Coli cells. We grew an overnight culture of the BL21 cells with our plasmids then diluted our cells to a standardized OD600 of ~0.1 and let it grow until an OD600 of 0.5~0.6. The diluted cultures of OD600 0.5~0.6 were then induced for expression with 0.5 M IPTG stock (to a final concentration of 0.5mM in the culture) and allowed to grow and induce overnight at room temperature.

T--TAS_Taipei--engineeringsucess3.png

Figure 3 - SDS-PAGE of cell lysate for each strain: T7 promoter α-N-Acetylgalactosaminidase (NAGA) and strong promoter (K88) α-N-Acetylgalactosaminidase (NAGA). Blue triangles indicate expected size for NAGA (50.1 kDa). Sequences for target proteins do not contain a start codon, thus have no expression, as shown by the triangles.


Our SDS-page did not show any overexpression bands for the enzymes of interest. The results indicate that there were no target proteins at their expected band sizes: 50.1 kDa band for both T7 promoter + NAGA and K88 promoter + NAGA in the induced sample. As the SDS page is of cell lysis samples, other bands present are due to innate proteins present in the bacteria cell.

Upon comparison of the amino acid sequence from Tuebingen’s part (BBa_K1483000) with full sequences that were offered by other studies online, we discovered that the enzyme sequences were missing the start codon (Fig #), which explained the non-expression of the proteins.


T--TAS_Taipei--nagaaminoacids.jpg

Figure 4 - Top sequence: First 37 amino acids of Team Tuebingen's 2014

α-N-Acetylgalactosaminidase part BBa_K1483000. Bottom sequence: First 38 amino acids of TAS_Taipei's α-N-Acetylgalactosaminidase part BBa_K3717016. Based on the alignment of the two sequences, Tuebingen's part is missing the first amino acid of the α-N-Acetylgalactosaminidase protein.


References

Rahfeld, Peter, and Stephen G. Withers. “Toward Universal Donor Blood: Enzymatic Conversion of A and B to O Type.” Journal of Biological Chemistry, vol. 295, no. 2, Jan. 2020, pp. 325–34. DOI.org (Crossref), https://doi.org/10.1074/jbc.REV119.008164.

XTractorTM Buffer & xTractor Buffer Kit User Manual. (n.d.). 10.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 7
    Illegal NheI site found at 30
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 468